FDA Guidance for Industry: Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending Monograph Process
Title:
FDA Guidance for Industry: Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending
Monograph Process
Origin/Publisher:
FDA
Content:
This guidance assists applicants and drug master file (MF) holders in the initiation of either revisions to an existing monograph(s) or development of a new monograph(s) under the United States Pharmacopeial Convention Pending Monograph Process (USP-PMP) during FDA’s evaluation of a drug master file or drug product application.